Advertisement

Topics

Latest "BioTech Capital Limited" News Stories

16:23 EST 20th February 2018 | BioPortfolio

Here are the most relevant search results for "BioTech Capital Limited" found in our extensive news archives from over 250 global news sources.

More Information about BioTech Capital Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioTech Capital Limited for you to read. Along with our medical data and news we also list BioTech Capital Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioTech Capital Limited Companies for you to search.

Showing "BioTech Capital Limited" News Articles 1–25 of 10,000+

Tuesday 20th February 2018

Aimmune Therapeutics Announces Proposed Public Offering of Common Stock

Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it has commenced an underwritten public offering of up to $150,000,000 of shares of its common stock. All of the shares to be sold in the offering will be offered by Aimmune. In addition, Aimmune ...


Powder PhytasesIndia Market Status and Trend Report 20132023 [Report Updated: 12022018] Prices from USD $2980

Report SummaryPowder PhytasesIndia Market Status and Trend Report 20132023 offers a comprehensive analysis on Powder Phytases industry, standing on the readers' perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report inc...

20152023 World MultiWalled Carbon Nanotubes Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 01072017] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...


Correction to the regulatory release of BBS-Bioactive Bone Substitutes Plc published on 20.02.2018 at 16:00 CET

The portion of the New Shares to be issued in the IPO was announced to be 14.30 percent of the Company's shares. The correct number is 12.50 percent. The corrected company announcement is presented below: The initial public offering of BBS-Bioactive Bone Substitutes Plc ended. Listing at the Nasdaq First North Finland and Sweden marketplaces have been applied - Trading begins ab...

Bone Therapeutics SA strengthens Board with the appointment of Jean Stéphenne as Chairman

Regulated information Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman Jean Stéphenne brings extensive biotech and pharma experience Gosselies, Belgium, 20 February 2018, 6 pm CET - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone d...

Wikia, Inc.'s FANDOM Announces Investment Led by Media Veteran Jon Miller

The investment will provide Wikia, Inc. with industry-leading resources and significant operating and growth capital for the market-leading FANDOM brand. As part of the investment, Read more...

#jobs #lifescience Strategy Advisor, Performance Improvement (Strategy) (Life Sciences) (Manager) (Multiple Positions)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Strategy Advisor, Performance Improvement (Strategy) (Life Sciences) (Manager) (Multiple Positions) .NJ-Iselin, Strategy Advisor, Performance Improvement (Strategy) (Life Sciences) (Manager) (Multiple Positions), Ernst & Young U.S. LLP, Iselin, NJ. … Continue readin...

TractManager Acquires Newport Credentialing Solutions

TractManager, Inc., the healthcare industry’s largest supplier of strategic sourcing and contract lifecycle management (CLM) solutions, has acquired Newport Credentialing Solutions, the leader in cloud-based credentialing a

Virginia Catalyst Awards $400,000 to Help Reduce Neonatal and Infant Death

The Virginia Biosciences Health Research Corporation, known as Virginia Catalyst, has awarded a $400,000 grant to a collaborative bioscience commercialization project including a team from Virginia Commonwealth University, Eastern Virginia Medical School and ReAlta Life Sciences, LLC. This grant, which includes matching funding of $400,000 provided by ReAlta, is intended to establish the efficacy ...

California’s Orange County Inland Empire SBDC Network Announces Partnerships with the University of California Irvine and Riverside to Assist Tech Entrepreneurs in SoCal

New Partners to Offer a Suite of Services to Assist Tech Companies with Access to Capital, Talent Pools and Business Development Expertise FULLERTON, Calif. (PRWEB) February 20, 2018 Orange County Inland Empire Small Business Development Center (OCIE SBDC) Network Headquarters (Fullerton, CA) – The OCIE SBDC Network hosted by California State University, Fullerton, one of the state’s principa...

#jobs #lifescience Kelly Scientific Resources: Algorithm Engineer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Kelly Scientific Resources: Algorithm Engineer . Not specified: Kelly Scientific Resources: Kelly Engineering is working with a leading Medical Devices organisation who are looking to recruit an Algorithm … Continue reading → Cet article #jobs #lifescience Kelly Sc...

Global Clinical Trial Management System Market Analysis & Trends 2015-2017 & Industry Forecast 2017-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trial Management System Market Analysis & Trends – Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Clinical Trial Management System Market is poised to grow strong during the forecast period 2017 … Continue reading → Cet article Global Clinical Trial Ma...

Global Bi-Specific Antibodies Market Forecast 2018-2022 – Anticipated to Witness Double Digit Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Bi-Specific Antibodies Market Forecast to 2022” report has been added to ResearchAndMarkets.com’s offering. According to the report, the Global Bi-Specific Antibodies Market is anticipated to witness a double digit growth during the forecast period. The report provides … Continue reading → Cet article Global Bi-Specific A...

Global & US Gene Therapy Market Forecast to 2018-2020: Rising Focus to Accelerate Commercialization of Gene Therapy in Developed Nations – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global & US Gene Therapy Market Forecast to 2020” report has been added to ResearchAndMarkets.com’s offering. According to the report, most of the gene therapy researches are being focused on finding the treatment for cancer, followed by genetic … Continue reading → Cet article

What does the UK Life Sciences Strategy mean for the pharma and biotech sector?

Edward Jones, a policy and communications consultant at independent London-based strategic communications…

The initial public offering of BBS-Bioactive Bone Substitutes Plc ended. Listing at the Nasdaq First North Finland and Sweden marketplaces have been applied - Trading begins about 28.02.2018

BBS-BIOACTIVE BONE SUBSTITUTES PLC COMPANY ANNOUNCEMENT 20 FEBRUARY 2018 AT 17:00 EET Not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, Hong Kong, South Africa, Singapore, Japan, New Zealand or any other country, in which the publication or distribution of this presentation would be unlawful. The IPO (as defined below) of ...

#news #biotech Ionis farms out antisense drug to AstraZeneca in deal worth up to $330M

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ionis farms out antisense drug to AstraZeneca in deal worth up to $330M .Ionis Pharmaceuticals has licensed an antisense drug for the treatment of kidney disease to AstraZeneca, … Continue reading → Cet article #news #biotech Ionis farms out antisense drug to Astra...

Cognate Completes Management Buyout and Raises Growth Capital to Fund Commercial Cellular Therapy Manufacturing Expansion

Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms including Santa Monica, Calif.-based

AGILENT HP 8478B PROBE 10MHz to 18GHz THERMISTOR MOUNT *G790

1,00 EUR (0 Pujas)Fecha de finalización: miércoles feb-28-2018 20:14:43 CETPujar ahora | Añadir a lista de seguimiento Biotech365 : AGILENT HP 8478B PROBE 10MHz to 18GHz THERMISTOR MOUNT *G790 BioMarketplace You want to propose your products or a Biotech Company, … Continue reading → Cet article AGILENT HP 8478B PROBE 10MHz to 18GHz THERMISTOR MOUNT *G790 est apparu en premier...

MediSpend to Host GDPR Workshop at Flemings’s 6th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry Conference

MediSpend CEO to discuss data privacy concerns and the use of healthcare data PORTSMOUTH, N.H. (PRWEB) February 20, 2018 MediSpend, the leading compliance cloud solution software provider for the life sciences industry will facilitate an interactive General Data Protection Regulation (GDPR) workshop in advance of the Fleming Corporate Compliance and Transparency in the Pharmaceutical Industry Con...

MOLOGEN AG enters into financing agreement with Alpha Blue Ocean's European High Growth Opportunities Securitization Fund

DGAP-News: MOLOGEN AG / Key word(s): Corporate Action/Financing 20.02.2018 / 15:38 The issuer is solely responsible for the content of this announcement. PRESS RELEASE N 4 / 2018 of 20/02/2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD...

#jobs #lifescience Children’s Hospital of Philadelphia: Research Post Doc Fellow – Pediatric Cancer Immuno-oncology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Children’s Hospital of Philadelphia: Research Post Doc Fellow – Pediatric Cancer Immuno-oncology . Competitive Salary: Children’s Hospital of Philadelphia: Children’s Hospital of Philadelphia seeks a Research Post Doc … Continue reading → Ce...

MOLOGEN AG: Financing agreement to subscribe convertible bonds for an aggregate amount of up to EUR 12 million

MOLOGEN AG / Key word(s): Corporate Action/Financing MOLOGEN AG: Financing agreement to subscribe convertible bonds for an aggregate amount of up to EUR 12 million 20-Feb-2018 / 15:31 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of t...

MOLOGEN AG enters into financing agreement with Alpha Blue Ocean’s European High Growth Opportunities Securitization Fund

DGAP-News: MOLOGEN AG / Key word(s): Corporate Action/Financing 20.02.2018 / 15:38 The issuer is solely responsible for the content of this announcement. PRESS RELEASE N 4 / 2018 of 20/02/2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN … Continue reading → Cet article MOLOGEN AG enters into financing agreement with Alpha Blue Ocean’s European High Gr...

QTY 3 HP AGILENT KEYSIGHT 8120-2703 ATTENUATOR CONTROL CABLE

C $28.27 (2 Bids)End Date: Monday Feb-26-2018 16:25:48 ESTBid now | Add to watch list Biotech365 : QTY 3 HP AGILENT KEYSIGHT 8120-2703 ATTENUATOR CONTROL CABLE BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading → Cet article QTY 3 HP AGILENT KEYSIGHT 8120-2703 ATTENUATOR CONTROL CABLE est apparu en premier sur Biotech 365.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks